Atlas Trials

CG Oncology, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CG Oncology, Inc.

RecordFirmDate
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC (NCT06567743)CG Oncology, Inc.2024-09-16
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT (NCT06111235)CG Oncology, Inc.2023-12-14
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin (NCT04387461)CG Oncology, Inc.2020-12-08
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin (NCT04452591)CG Oncology, Inc.2020-10-27

Track CG Oncology, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.